Stock EIGR EIGER BIOPHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

MarketScreener Strategies Eiger BioPharmaceuticals, Inc.

Equities

EIGR

US28249U2042

Delayed OTC Markets
Other stock markets
 10:13:27 2024-06-26 EDT 		5-day change 1st Jan Change
13.2 USD +1.15% Intraday chart for Eiger BioPharmaceuticals, Inc. +32.00% +95.99%
06-21 Amylyx to buy bankrupt Eiger's experimental drug to treat low blood sugar RE
05-08 Sentynl Therapeutics, Inc. acquired Global rights to Zokinvy Eiger BioPharmaceuticals, Inc. (OTCPK:EIGR.Q) for $45.2 million. CI

MarketScreener Strategies

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. EIGR Stock
  4. News Eiger BioPharmaceuticals, Inc.
  5. MarketScreener Strategies